MASTER: A Randomized, Double-Blinded, Controlled, Parallel Group, Non inferiority, Phase III Study to Evaluate the Efficacy and Safety of the INTERCEPT Blood System for Red blood Cells in Patients Undergoing Complex Cardiac Surgery Procedures (the ReCePI

Project: Research project

Description

MASTER: A Randomized, Double-Blinded, Controlled, Parallel Group, Non inferiority, Phase III Study to Evaluate the Efficacy and Safety of the INTERCEPT Blood System for Red blood Cells in Patients Undergoing Complex Cardiac Surgery Procedures (the ReCePI
StatusActive
Effective start/end date5/17/195/16/24

Funding

  • CERUS CORPORATION

Fingerprint

Blood Safety
Thoracic Surgery
Erythrocytes